12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Tuesday's intraday session, several healthcare stocks experienced significant movements. Palisade Bio, China SXT Pharmaceuticals, Dynatronics, Jaguar Health, BioSig Technologies, and Intra-Cellular Therapies were among the gainers, with increases ranging from 26.49% to 65.1%. Conversely, Calidi Biotherapeutics, Pacific Biosciences, Portage Biotech, Nexalin Technology, PaxMedica, and Adlai Nortye were the losers, with decreases ranging from 17.81% to 58.5%.
April 16, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Pacific Biosciences stock decreased by 44.98% to $1.56, with a market cap of $418.0 million.
The significant drop in Pacific Biosciences' stock price could be due to negative news, disappointing earnings, or bearish market sentiment towards the biotech sector.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Palisade Bio stock surged 65.1% to $6.87, with a market cap of $5.8 million.
The significant surge in Palisade Bio's stock price indicates strong investor interest, potentially due to positive company developments or market conditions favoring healthcare stocks.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
China SXT Pharmaceuticals shares rose 54.7% to $1.81, with a market value of $1.0 million.
The substantial increase in China SXT Pharmaceuticals' stock price could reflect investor optimism about the company's prospects or broader sector trends.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90